跳至主要内容
临床试验/TCTR20210928001
TCTR20210928001Enrolling By Invitation4 期

Effect of branched-chain amino acid supplements on frailty liver index in patients with liver cirrhosis

Thammasat University0 个研究点目标入组 52 人开始时间: 2021年9月28日最近更新:
适应症

试验速览

阶段
4 期
状态
Enrolling By Invitation
入组人数
52

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • 1.Adults who diagnosed cirrhosis
  • 2.Liver frailty index more than 4.5

排除标准

  • 1.Patitents who recieved branch chain amino acid in 1 year
  • 2.Patients was diagnosed hepatic encephalopathy more than stage 2
  • 3.Patients was diagnosed hepatocellular carcinoma
  • 4.Patients was diagnosed malignancy or severe comorbidity which survival less than 6months Exp congestive heart failure , COPD , ESRD
  • 5.Pregnancy and breast feeding
  • 6.Patients was post organ transplant
  • 7.Patients was admit in hospital within 1 month
  • 8.Patients was poor diabetic control (HbA1c more than 8.5)

研究者

相似试验